Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Toxicol Appl Pharmacol ; 436: 115862, 2022 02 01.
Article in English | MEDLINE | ID: mdl-34998853

ABSTRACT

While a considerable body of literature has characterized the clinical features induced by organophosphate pesticides, the field lacks scrutiny into cardio-respiratory changes in different phases of poisoning. Herein, we evaluated the impact of chlorpyrifos (CPF) and its active metabolite chlorpyrifos-oxon (CPO) on the cardiorespiratory system during acute and subacute phases of poisoning using an in situ experimental rodent model. CPF (30 mg/kg) was injected intraperitoneally to rats beforehand (24 h) whereas CPO (15 mg/kg) was added into the perfusate reservoir to evaluate the effects on the motor outputs throughout the three phases of the respiratory cycle: inspiration, post-inspiration and late expiration. Phrenic, recurrent laryngeal (RLN) and thoracic sympathetic nerve activity (tSNA) were recorded. Heart rate was derived from the electrocardiogram (ECG) and the baro- and chemo-reflexes tested. CPF and CPO led to a time-dependent change in cardiorespiratory motor outputs. In the acute phase, the CPO induced bradypnea, transiently reduced the inspiratory time (TI), and increased the amplitude of phrenic. Post-inspiratory (PI) discharge recorded from the RLN was progressively reduced while tSNA was increased. CPO significantly depressed the chemoreflex but had no effect on baroreflex. During subacute phase, CPF prolongated TI with no effect on respiratory rate. Both the RLN PI discharge, the chemoreflex and the baroreflex sympathetic gain were reduced. In addition, both CPF and CPO shifted the cardiac sympatho-vagal balance towards sympathetic dominance. Our data show that different phases of poisoning are associated with specific changes in the cardio-respiratory system and might therefore demand distinct approaches by health care providers.


Subject(s)
Baroreflex/drug effects , Chlorpyrifos/adverse effects , Heart Rate/drug effects , Heart/drug effects , Respiratory System/drug effects , Animals , Chlorpyrifos/analogs & derivatives , Cholinesterase Inhibitors/adverse effects , Insecticides/adverse effects , Male , Rats , Rats, Wistar , Respiratory Rate/drug effects
3.
Toxicology ; 398-399: 13-22, 2018 04 01.
Article in English | MEDLINE | ID: mdl-29471072

ABSTRACT

Although it is well-established that severe poisoning by organophosphorus (OP) compounds strongly affects the cardiorespiratory system, the effects of sub-lethal exposure to these compounds on the neural control of cardiovascular function are poorly explored. The aim of this study was to evaluate the effects of acute sub-lethal exposure to chlorpyrifos (CPF), a commonly used OP insecticide, on three basic reflex mechanisms involved in blood pressure regulation, the peripheral chemoreflex, the baroreflex and the Bezold-Jarisch reflex. Adult male Wistar rats were injected intraperitoneally with a single dose of CPF (30 mg/kg) or saline (0.9%). 24 h after injections, cardiovascular reflexes were tested in awake rats. Potassium cyanide (KCN) and phenylbiguanide (PBG) were injected intravenously to activate the chemoreflex and the Bezold-Jarisch reflex, respectively. The baroreflex was activated by phenylephrine and sodium nitroprusside infusions. Blood samples were taken for measurements of butyrylcholinesterase (BChE) activity while acetylcholinesterase (AChE) activity was measured in brainstem samples. Animals treated with CPF presented signs of intoxication such as ataxia, tremor, lacrimation, salivation, tetany, urination and defecation. The hypertensive and the bradycardic responses of the chemoreflex as well as the hypotensive and bradycardic responses of the Bezold-Jarisch reflex were attenuated in CPF treated animals (P < 0.05). Concerning the baroreflex responses, CPF treatment reduced the bradycardia plateau, the range and the gain of the reflex (P < 0.05). Plasma BChE and brainstem AChE were both reduced significantly after CPF treatment (P < 0.05). Our results showed that acute sub-lethal exposure to CPF impairs the cardiovascular responses of homeostatic and defensive cardiovascular reflexes. These effects are associated with a marked inhibition of plasma BChE and brainstem AChE.


Subject(s)
Baroreflex/drug effects , Brain Stem/drug effects , Chlorpyrifos/toxicity , Acetylcholinesterase/blood , Acetylcholinesterase/metabolism , Animals , Brain Stem/enzymology , Butyrylcholinesterase/blood , Butyrylcholinesterase/metabolism , Cholinesterase Inhibitors/toxicity , GPI-Linked Proteins/blood , GPI-Linked Proteins/metabolism , Insecticides/toxicity , Male , Pilot Projects , Rats , Rats, Wistar , Toxicity Tests, Acute
4.
Brain Res ; 1542: 93-103, 2014 Jan 13.
Article in English | MEDLINE | ID: mdl-24177045

ABSTRACT

The cardioinhibitory effects of cardiac vagal motoneurons (CVMs) are mediated by activation of postganglionic neurons in the epicardial ganglia which have been shown to exert functionally selective effects on heart rate and atrioventricular conduction in the rat. Here we investigate whether CVMs producing these responses may occupy different rostrocaudal positions within the nucleus ambiguus. Excitation of CVMs was attempted by microinjections of glutamate into the nucleus ambiguus of an arterially perfused preparation in a grid extending over 2mm in the rostrocaudal plane using the obex as a reference point. Microinjections were paired, one made during pacing to measure changes in atrioventricular conduction (P-R interval) independent of changes in heart rate and the other looking for changes in heart period (P-P interval) un-paced. Although evidence of a differential distribution was found in 7 cases, in the majority (13/20), sites producing maximal effects on both variables coincided. Maximal changes in atrioventricular conduction resulted from more rostral sites in 6 cases and from a more caudal site in only one. Overall, the ratio of the change in atrioventricular conduction to the change in heart rate for a given site was significantly greater 1mm rostral to the obex than at either end of the test grid. We conclude that while CVMs controlling atrioventricular conduction are distributed with a peak somewhat rostral to those controlling heart rate in a number of animals, there is a significant overlap and much greater variability in this distribution in the rat than in cats and dogs.


Subject(s)
Excitatory Amino Acid Agonists/pharmacology , Glutamic Acid/pharmacology , Heart Conduction System/drug effects , Heart Rate/drug effects , Nucleus Accumbens/drug effects , Animals , Biotin/analogs & derivatives , Biotin/metabolism , Blood Pressure/drug effects , Electrocardiography , Heart Conduction System/physiology , Lysine/analogs & derivatives , Lysine/metabolism , Microinjections , Rats , Rats, Sprague-Dawley , Vagus Nerve/drug effects , Vagus Nerve/physiology
5.
Exp Physiol ; 96(3): 262-74, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21148626

ABSTRACT

Anatomical studies have demonstrated the existence of purinergic P2 receptors in the nucleus ambiguus (NA), a site containing cardiac vagal motoneurons. However, very little is known about the functional role of these receptors in central cardiac vagal regulation. The aims of our study were to evaluate the following: (1) the blood pressure and heart rate responses following purinoceptor activation within the NA; (2) the role of purinoceptors and excitatory amino acid (EAA) receptors in mediating the cardiovascular responses evoked by ATP and L-glutamate stimulation of NA; and (3) the role of NA purinoceptors in mediating the cardiovascular responses of the Bezold-Jarisch reflex. In anaesthetized rats, microinjection of L-glutamate (5.0 nmol/50 nl) into the NA induced a marked and immediate onset bradycardia with minimal change in arterial pressure. Microinjection of ATP into the NA induced a dose-dependent (0.31-6.0 nmol/50 nl) bradycardia and pressor responses. It is noteworthy that the bradycardia occurred either before or simultaneously with a pressor response (when present), indicating that it was not a baroreceptor reflex mediated response due to the rise in arterial pressure. The pressor response was prevented by α(1)-adrenergic blockade with prazosin, whereas muscarinic blockade with methyl-atropine abolished the evoked bradycardia. Ipsilateral microinjection of PPADS (a P2 receptor antagonist; 500 pmol/100 nl) into the NA significantly attenuated the ATP-induced bradycardia but spared the pressor response. In contrast, PPADS in the NA had no effect on the L-glutamate-evoked bradycardic response. Ipsilateral injection of kynurenic acid (a non-selective EAA receptor antagonist; 10 nmol/50 nl) into the NA totally blocked the bradycardia induced by l-glutamate and partly attenuated the ATP induced bradycardia. Finally, both the depressor and the bradycardic responses of the Bezold-Jarisch reflex were attenuated significantly (P < 0.01 and P < 0.05, respectively) following bilateral microinjection of PPADS into the NA. These results identify ATP and purinergic P2 receptors within the ventrolateral medulla as excitatory to cardiovagal neurons. Additionally, our data show that P2 receptors within the ventrolateral medulla are integral to the cardiovascular responses of the Bezold-Jarisch reflex.


Subject(s)
Cardiovascular System/innervation , Medulla Oblongata/physiology , Receptors, Purinergic P2/physiology , Adenosine Triphosphate/pharmacology , Adrenergic alpha-1 Receptor Antagonists/pharmacology , Animals , Atropine Derivatives/pharmacology , Baroreflex/drug effects , Baroreflex/physiology , Blood Pressure/drug effects , Cardiovascular System/drug effects , Cardiovascular System/metabolism , Excitatory Amino Acid Antagonists/pharmacology , Glutamic Acid/pharmacology , Heart Rate/drug effects , Kynurenic Acid/pharmacology , Male , Medulla Oblongata/metabolism , Muscarinic Antagonists/pharmacology , Prazosin/pharmacology , Purinergic P2 Receptor Antagonists/pharmacology , Pyridoxal Phosphate/analogs & derivatives , Pyridoxal Phosphate/pharmacology , Rats , Rats, Wistar , Receptors, Glutamate/metabolism , Receptors, Purinergic P2/metabolism , Vagus Nerve/drug effects , Vagus Nerve/physiology
6.
Toxicon ; 55(2-3): 580-9, 2010.
Article in English | MEDLINE | ID: mdl-19879286

ABSTRACT

The aim of the present study was to investigate the cardiovascular activity of Scorpaena plumieri venom in both in vivo and in vitro models. In anesthetized rats, doses of the venom (14-216 microg protein/kg) induced a transient increase in the mean arterial pressure. However at higher dose (338 microg protein/kg) this effect was followed by a sudden hypotension and the animal evolved to death. The heart rate was temporarily increased and followed by bradycardia using doses > or =108 microg/kg. In isolated rat hearts the crude venom (5-80 microg protein) produced dose-dependent positive ventricular chronotropic, inotropic, lusitropic and coronary vasoconstriction responses. Partial purification of an active fraction (CF, cardiovascular fraction) which reproduced the cardiovascular effects induced by crude venom on isolated hearts was achieved by conventional gel filtration chromatography. Adrenergic blockades, prazosin and propranolol, significantly attenuated these responses. The coronary vasoconstriction response to CF was also attenuated by chemical endothelium denudation. In conclusion, the data showed that S. plumieri fish venom induces disorders in the cardiovascular system. It also suggests that alpha(1) and beta-adrenergic receptors, and the vascular endothelium, are involved at least partially, in these cardiac effects.


Subject(s)
Cardiovascular Diseases/chemically induced , Fish Venoms/toxicity , Fishes/physiology , Adrenergic alpha-Antagonists/pharmacology , Adrenergic beta-Antagonists/pharmacology , Animals , Blood Pressure/drug effects , Brazil , Cardiovascular Diseases/pathology , Chromatography, Gel , Dose-Response Relationship, Drug , Electrophoresis, Polyacrylamide Gel , Fish Venoms/antagonists & inhibitors , Fish Venoms/chemistry , Heart Rate/drug effects , Male , Myocardial Contraction/drug effects , Prazosin/pharmacology , Propranolol/pharmacology , Proteins/analysis , Rats , Rats, Wistar , Vasoconstriction/drug effects
7.
Exp Physiol ; 88(3): 315-27, 2003 May.
Article in English | MEDLINE | ID: mdl-12719756

ABSTRACT

Vagal cardioinhibition is exerted through a reduction not only in the heart rate but also in the rate of propagation of the cardiac action potential and in myocardial contractility. In several species, such effects can be produced independently by selective activation of ganglia in identified 'fat pads'. In this study we investigate differential control of heart rate and atrioventricular conduction by two ganglionic clusters in the rat, a species increasingly important in studies of cardiovascular control. Epicardial sites producing low-threshold changes in P-P and P-R interval of the ECG in an arterially perfused preparation were explored with concentric bipolar stimulating electrodes. Stimulation sites centred on two principal ganglia, the sinoatrial (SA) ganglion at the junction of the right superior vena cava and right atrium, and the atrioventricular (AV) ganglion at the junction of the inferior pulmonary veins and left atrium. Stimulation of the SA ganglion decreased heart rate in all preparations, with little or no effect on AV conduction in one-third. Stimulation of the AV ganglion consistently slowed conduction without eliciting a comparable bradycardia. Responses survived blockade of ganglionic transmission by trimetaphan, with an enhanced chronotropic selectivity to SA ganglion stimulation, suggesting that co-excitation of preganglionic elements en passant may have contributed to the earlier mixed responses. Effective stimulation sites were precisely circumscribed and corresponded to principal ganglionic clusters confirmed histologically. We conclude that cardiac vagal ganglia in the rat show a topographical functional organisation and are amenable to investigation using the arterially perfused preparation.


Subject(s)
Atrioventricular Node/innervation , Atrioventricular Node/physiology , Ganglia, Parasympathetic/physiology , Sinoatrial Node/innervation , Sinoatrial Node/physiology , Vagus Nerve/physiology , Animals , Arrhythmia, Sinus/physiopathology , Electric Stimulation , Ganglia, Parasympathetic/cytology , Ganglia, Parasympathetic/drug effects , Ganglionic Blockers/pharmacology , Heart Rate/physiology , Rats , Rats, Sprague-Dawley , Stimulation, Chemical , Sympathetic Nervous System/physiology , Trimethaphan/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...